BioAmber has no assets, no operations, no source of income, no board of directors, no executives, no management, no employees. It is a company on paper only. The assets were sold in bankruptcy liquidation, and the proceeds will barely cover 5% of its debt. Those are the results of the restructuring.
What, exactly, do we expect a debt ridden empty shell to be restructured into?
I'll wait.